Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease

Go back to Amgen And Provention Bio Announce Co-Development Collaboration In Celiac Disease
Amgen Inc (NASDAQ: AMGN) Delayed: 438.34 -0.6 (0.14%)
Previous Close $438.94    52 Week High $176.85 
Open $440.21    52 Week Low $133.64 
Day High $441.03    P/E 66.02 
Day Low $434.53    EPS $6.64 
Volume 2,610,616       

Powder River Basin & Gas Corporation (NASDAQ: PRVB) Delayed: 24.98 --0 (-0%)
Previous Close $24.98    52 Week High $0.17 
Open $41.76    52 Week Low $0.17 
Day High $24.98    P/E 499.60 
Day Low $24.98    EPS $0.05 
Volume 9,073,039